These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 10685738

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G, Manguso F, Miele E, Buonavolontà R, Staiano A.
    Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
    [Abstract] [Full Text] [Related]

  • 5. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP, Schenk E, Tan G, Snel P, Nelis F.
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [Abstract] [Full Text] [Related]

  • 6. A comparison of five maintenance therapies for reflux esophagitis.
    Vigneri S, Termini R, Leandro G, Badalamenti S, Pantalena M, Savarino V, Di Mario F, Battaglia G, Mela GS, Pilotto A.
    N Engl J Med; 1995 Oct 26; 333(17):1106-10. PubMed ID: 7565948
    [Abstract] [Full Text] [Related]

  • 7. Long-term maintenance treatment with omeprazole in children with healed erosive oesophagitis: a prospective study.
    Hassall E, Shepherd R, Koletzko S, Radke M, Henderson C, Lundborg P.
    Aliment Pharmacol Ther; 2012 Feb 26; 35(3):368-79. PubMed ID: 22176465
    [Abstract] [Full Text] [Related]

  • 8. Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Haber M.
    Am J Gastroenterol; 1996 Sep 26; 91(9):1758-65. PubMed ID: 8792694
    [Abstract] [Full Text] [Related]

  • 9. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.
    Wo JM, Grist WJ, Gussack G, Delgaudio JM, Waring JP.
    Am J Gastroenterol; 1997 Dec 26; 92(12):2160-5. PubMed ID: 9399745
    [Abstract] [Full Text] [Related]

  • 10. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
    Moretzsohn LD, Carvalho EB, Franco JD, Soares MP, Brito EM, Belarmino K, Coelho LG.
    Can J Clin Pharmacol; 2009 Dec 26; 16(1):e264-72. PubMed ID: 19383986
    [Abstract] [Full Text] [Related]

  • 11. Short and long-term outcome of medically treated reflux esophagitis.
    Pace F, Sangaletti O, Trapé E, Santalucia F, Bianchi Porro GB.
    Hepatogastroenterology; 1995 Apr 26; 42(2):131-4. PubMed ID: 7672761
    [Abstract] [Full Text] [Related]

  • 12. Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.
    Johnson DA, Benjamin SB, Vakil NB, Goldstein JL, Lamet M, Whipple J, Damico D, Hamelin B.
    Am J Gastroenterol; 2001 Jan 26; 96(1):27-34. PubMed ID: 11197282
    [Abstract] [Full Text] [Related]

  • 13. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
    Bardhan KD, Cherian P, Jones RB, Vaishnavi A, Manek S, Bishop A, Polak J, Brooks A, Morris P, Thompson M, D'Silva J, Parkin S, Patterson J, Gillon KR.
    Ital J Gastroenterol Hepatol; 1997 Dec 26; 29(6):515-9. PubMed ID: 9513825
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Reflux esophagitis: a comparative study of lansoprazole and omeprazole as short-term therapy. Preliminary report].
    Córdova-Villalobos JA, Ramírez-Barba EJ, Ramírez-Covarrubias JC.
    Rev Gastroenterol Mex; 1996 Dec 26; 61(4):306-9. PubMed ID: 9072780
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The role of omeprazole in healing and prevention of reflux disease.
    Klinkenberg-Knol EC.
    Hepatogastroenterology; 1992 Feb 26; 39 Suppl 1():27-30. PubMed ID: 1577392
    [Abstract] [Full Text] [Related]

  • 18. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C, Triantafyllou K, Mallas E, Triantafyllou G, Ladas SD.
    J Clin Gastroenterol; 2008 Jul 26; 42(6):744-9. PubMed ID: 18277886
    [Abstract] [Full Text] [Related]

  • 19. Maintenance therapy of gastroesophageal reflux disease patients with omeprazole.
    Tepes B, Stabuc B, Kocijancic B, Ivanusa M.
    Hepatogastroenterology; 2009 Jul 26; 56(89):67-74. PubMed ID: 19453031
    [Abstract] [Full Text] [Related]

  • 20. Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression.
    Kahaleh M, Van Laethem JL, Nagy N, Cremer M, Devière J.
    Endoscopy; 2002 Dec 26; 34(12):950-5. PubMed ID: 12471537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.